We are very pleased to announce our partnership in Indonesia by acquiring majority of shares & management control of PT Citra Pharma Indonesia from current shareholders. It will now operate under the new name PT Wellesta CPI Healthcare and will be based from Jakarta. PT Citra Pharma Indonesia is in successful operations for last 12-years and have been partner with MNC players in Pharma and Healthcare sector in the Indonesian market. PT Citra Pharma provides medical sales & marketing services to MNC in Indonesia with successful and compliant track record.

This company was founded by Pak Budi, Pak Chan, Pak Freddy & Pak Agus. At present PT Wellesta CPI is led by Pak Freddy Hidajat as President Director. Indonesia is one of the fastest growing pharmaceutical markets in Asia and offers us good opportunity to partner with present MNCs in the country & companies who want to enter Indonesian market.

Our goal is to provide high quality professional services and support provide high quality healthcare products at optimum price to improve health to masses. We foresee this partnership will help accomplish our Vision and Mission through PT Wellesta CPI Healthcare in Indonesia. Our focus would be driven through our dedicated efforts, strong in-market experience, determination and veracity.

Mr. Slamet Achmad has been appointed as Product Manager for PT. Wellesta CPI Indonesia, effective from 1th December 2019.

Mr. Slamet started his career at PT Dumex Indonesia as Medical Representative in 1992. In 1997, he then transited to a Medical Representative in PT Pfizer Indonesia. He was promoted to District Sales Manager in 2002 and Product Manager in 2005. In 2015, he joined PT Citra Pharma Indonesia as Product Manager.

We at Wellesta are very optimistic about Indonesian Healthcare Market & opportunities for Wellesta to progress. We are sure that Mr Slamet’s expertise will help achieve our Vision & Mission. Mr Slamet will report directly to Yohannes Sinaga, Country Manager of PT Wellesta CPI Indonesia.

We welcome Mr. Slamet to the Wellesta family and wish him great success in his new position.

Rosalina Saleh has been appointed as Country Group Head for Indonesia business w.e.f. 1st December, 2025. She is a seasoned player with more than 25 years of extensive experience in the Pharmaceutical industry from both medical and economic domains. Prior to joining Wellesta, she was the Head of Business Excellence and Execution at PT Novartis Indonesia where she managed marketing, business development, customer engagement, trade and strategic account management, training and digital transformation.

She began her career as a General Physician, practicing for five years before transitioning into the pharmaceutical industry. Over the years, she has held several leadership roles across both local and multinational companies, spanning Medical, Sales & Marketing, Market Access, Commercial Strategy, BD&L, and Digital Innovation.

She brings extensive experience in managing both Specialty and General Medicine portfolios and has led multiple corporate strategic initiatives to drive growth, expand JKN geographical coverage, strengthen business archetypes, and build private–public partnership programs. She has also played a key role in developing innovative business models. Most recently, she and her team successfully implemented a digital innovation strategy for one of Novartis Indonesia’s largest portfolio contributors, earning the prestigious Regional Innovation Award.

Rosalina Saleh holds a Master’s degree in Sharia Economics from Tazkia Islamic University and a Medical Doctor (MD) degree from the University of Indonesia. She is also a certified Physician and an Associate Sharia Wealth Planner.

We are sure that Rosalina Saleh’s experience and leadership will help achieve our vision and mission in Indonesia. She will report to Mr. Milan Paleja, Chairman and MD of Wellesta Group.

We welcome Rosalina Saleh to the Wellesta family and wish her great success in this new position.

We are pleased to announce that McDavid Dandan will take on an expanded role as Regional Lead for Supply Chain Management handling Philippines, Singapore, and Malaysia.

In this expanded capacity, McDavid will lead our regional supply chain operations across the Philippines, Singapore, and Malaysia. His responsibilities will include driving strategic alignment, enhancing operational efficiency, improving forecast accuracy, and ensuring supply continuity. He will also focus on optimizing logistics performance, reinforcing supplier collaboration, and leveraging regional synergies to support Wellesta’s long-term growth and cross-market expansion strategies.

McDavid brings over 20 years of extensive experience in the pharmaceutical and healthcare sectors, with a solid foundation in both Supply Chain Management and Commercial Operations. He is a registered Pharmacist and holds a Postgraduate Diploma in Supply Chain Management.

Before joining Wellesta Philippines in January 2023 as Supply Chain & Business Development Manager, McDavid held leadership roles at Boehringer Ingelheim and AstraZeneca. Since then, he has played a vital role in strengthening our local supply chain, and we are confident that this expanded role will further accelerate our regional capabilities and growth.

He will report to Milan Paleja, Chairman and MD of Wellesta Group for his regional role and continue to report to Carla Aquino-Ong, Country Head of Wellesta Philippines for local responsibilities.

Please join us in congratulating McDavid on this well-deserved expanded role and wish him great success as he takes on this new opportunity.

Wellesta Holding, dengan senang hati mengumumkan penunjukkan Bpk Yohannes Sinaga (Mr Joe) sebagai Country Manager PT Wellesta CPI Indonesia, efektif per 1 Mei 2020.

Posisi terakhir Mr Joe adalah sebagai Chief Marketing Officer di AstraZeneca Indonesia. Beliau memiliki pengalaman yang luas dengan lebih dari 15 tahun bekecimpung di bidang industry farmasi. Mr. Joe mempunyai pengalaman di industri farmasi baik di sales dan marketing di berbagai bidang terapeutik, serta terlibat dengan berbagai asosiasi kedokteran, diantaranya asosiasi dokter anak, psikiatri, penyakit dalam, hematologi – onkologi, patologi, bedah, pulmonology, hepatology, nefrologi, neurologi, rematologi, ginekologi, serta stakeholder dari pemerintah.

Mr. Joe memulai karir sebagai Product Specialist di PT Novartis Indonesia, kemudian sebagai Product Manager. Setelah kurang lebih 5 tahun di PT Novartis, di tahun 2011, beliau bergabung dengan PT Roche, dimana disini, ia mendapatkan berbagai jenis posisi, mulai dari Group Product Manager, kemudian mendapat jabatan sebagai Business Unit Head baik di divisi specialty products dan juga di divisi Oncology. Di tahun 2016, beliau bergabung dengan PT AstraZeneca juga dengan role yang beragam, mulai dari Direktur Unit Bisnis Respiratory dan Core, kepala Learning dan Development serta terakhir sebagai Chief Marketing Officer. Beliau juga merupakan Champion dari International Marketing Excellence yang bertugas untuk menetapkan strategi Respiratory di Region International AstraZeneca.

Mr. Joe lulusan Farmasi Unpad serta memperoleh pendidikan MBA dari IPMI International Business School Jakarta.

Dengan market dan peluang yang besar di Indonesia, kita optimis, bahwa Wellesta akan berkembang pesat, serta dibawah kepemimpinan Mr. Joe, Wellesta CPI akan mencapai visi dan misi perusahaan.

Kami sangat senang hati mengumumkan kemitraan kami di Indonesia dengan mengakuisisi mayoritas saham & kontrol manajemen PT Citra Pharma Indonesia dari pemegang saham saat ini. Sekarang akan beroperasi dengan nama baru PT Wellesta CPI Healthcare dan akan berbasis dari Jakarta. PT Citra Pharma Indonesia telah beroperasi selama 12 tahun terakhir dan telah bermitra dengan para pemain MNC di sektor Farmasi dan Kesehatan di pasar Indonesia. PT Citra Pharma menyediakan layanan penjualan & pemasaran medis kepada MNC di Indonesia dengan rekam jejak yang sukses dan mengutamakan kepatuhan.

Perusahaan ini didirikan oleh Pak Budi, Pak Chan, Pak Freddy & Pak Agus. Saat ini PT Wellesta CPI dipimpin oleh Pak Freddy Hidajat sebagai Direktur Utama. Indonesia adalah salah satu pasar farmasi dengan pertumbuhan tercepat di Asia dan menawarkan kami kesempatan yang baik untuk bermitra dengan MNC masa kini di negara ini & perusahaan yang ingin memasuki pasar Indonesia.

Tujuan kami adalah untuk memberikan layanan dan dukungan profesional berkualitas tinggi menyediakan produk perawatan kesehatan berkualitas tinggi dengan harga optimal untuk meningkatkan kesehatan kepada masyarakat. Kami meramalkan kemitraan ini akan membantu mencapai Visi dan Misi kami melalui PT Wellesta CPI Healthcare di Indonesia. Fokus kami akan didorong melalui upaya berdedikasi kami, pengalaman, tekad, dan kebenaran di pasar yang kuat.

Slamet Achmad telah ditunjuk sebagai Product Manager untuk untuk PT. Wellesta CPI Indonesia berlaku mulai 1 Desember 2019.

Slamet memulai karirnya di PT Dumex Indonesia sebagai Medical Representative pada tahun 1992 dan bergabung di PT Pfizer Indonesia sebagai Medical Representative pada tahun 1997. Dia mendapatkan promosi menjadi District Sales Manager di tahun 2002 dan Product Manager di tahun 2005. Slamet mulai bergabung di PT Citra Pharma Indonesia sebagai Product Manager sejak tahun 2015.

Kami di Wellesta sangat optimis dengan Pasar Kesehatan Indonesia & peluang bagi Wellesta untuk maju. Kami yakin bahwa dengan keahlian Slamet akan membantu mencapai Visi & Misi kami. Slamet akan melapor kepada Marketing Head PT Wellesta CPI.

Kami menyambut Slamet untuk keluarga Wellesta dan berharap kesuksesan besarnya dalam posisi barunya